Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

Absztrakt
Leírás
Kulcsszavak
Forrás
Arthritis & Rheumatology. - 69 : 2 (2017), p. 362-375. -Arthritis & Rheumatology. - 2326-5191